Literature DB >> 23173113

Conductive keratoplasty: an approach for the correction of residual hyperopia in post-lasik pseudophakia.

Pan-Pan Ye1, Wen Xu, He-Sheng Xu, Zhao-Chun Li, Jun-Ting Shi, Feng-Ying He, Ke Yao.   

Abstract

Although there are many formulae for the calculation of intraocular lens power in the eyes with previous kerato-refractive surgeries, unexpected refractive bias still exists. Hyperopic bias is particularly disliked because it affects both uncorrected distance and near visual acuity. Surgical treatment of the residual hyperopia for the eyes with both laser in situ keratomileusis and cataract surgery remains to be a big problem. Conductive keratoplasty has been shown to be an effective, safe and predictable method for low and moderate hyperopia in the pseudophakic eyes or in the eyes with kerato-refractive surgeries. However, the efficacy and safety of conductive keratoplasty in the correction of residual hyperopia after both corneal and lens refractive surgeries has not been reported. Herein, we reported the surgical correction with conductive keratoplasty for cases of residual hyperopia with/without astigmatism after previous laser in situ keratomileusis for high myopia and following phacoemulsification combined with posterior intraocular lens implantation for complicated cataract.

Entities:  

Keywords:  conductive keratoplasty; hyperopia; laser in situ keratomileusis; pseudophakia

Year:  2012        PMID: 23173113      PMCID: PMC3484695          DOI: 10.3980/j.issn.2222-3959.2012.05.17

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  12 in total

1.  Conductive keratoplasty for the correction of hyperopia.

Authors:  P A Asbell; R K Maloney; J Davidorf; P Hersh; M McDonald; E Manche
Journal:  Trans Am Ophthalmol Soc       Date:  2001

2.  Analysis of elements of interlenticular opacification.

Authors:  Liliana Werner; David J Apple; Suresh K Pandey; Kerry D Solomon; Michael E Snyder; Stephen F Brint; Johnny L Gayton; Joel K Shugar; Rupal H Trivedi; Andrea M Izak
Journal:  Am J Ophthalmol       Date:  2002-03       Impact factor: 5.258

3.  Conductive keratoplasty to correct residual hyperopia after corneal surgery.

Authors:  Ian F Comaish; Michael A Lawless
Journal:  J Cataract Refract Surg       Date:  2003-01       Impact factor: 3.351

4.  Conductive keratoplasty to treat hyperopic overcorrection after LASIK for myopia.

Authors:  John S M Chang; Silvania Y F Lau
Journal:  J Refract Surg       Date:  2010-02-15       Impact factor: 3.573

5.  Conductive keratoplasty to treat complications of LASIK and photorefractive keratectomy.

Authors:  Peter S Hersh; Kristen L Fry; Ravindra Chandrashekhar; Desipina S Fikaris
Journal:  Ophthalmology       Date:  2005-09-12       Impact factor: 12.079

6.  Conductive keratoplasty for the treatment of astigmatism induced by corneal trauma or incision.

Authors:  Wen Xu; Panpan Ye; Ke Yao; Jin Ma; Hesheng Xu
Journal:  J Refract Surg       Date:  2010-01-11       Impact factor: 3.573

7.  Pupillary block glaucoma associated with a secondary piggyback intraocular lens.

Authors:  Shane K Kim; Ralph C Lanciano; Michael E Sulewski
Journal:  J Cataract Refract Surg       Date:  2007-10       Impact factor: 3.351

8.  Regression of effect over long-term follow-up of conductive keratoplasty to correct mild to moderate hyperopia.

Authors:  Jason S Ehrlich; Edward E Manche
Journal:  J Cataract Refract Surg       Date:  2009-09       Impact factor: 3.351

9.  Intraocular lens power calculation after refractive surgery.

Authors:  Carlos Argento; María José Cosentino; Daniel Badoza
Journal:  J Cataract Refract Surg       Date:  2003-07       Impact factor: 3.351

10.  Conductive keratoplasty for presbyopia: 3-year results.

Authors:  Jason E Stahl
Journal:  J Refract Surg       Date:  2007-11       Impact factor: 3.573

View more
  1 in total

1.  Study of minimally invasive radiofrequency ablation of the ciliary body for the treatment of glaucoma in rabbits.

Authors:  Baoke Hou; Fengxiang Wang; Zi Ye; Xin Jin; Yu Fu; Zhaohui Li
Journal:  Mol Med Rep       Date:  2019-12-31       Impact factor: 2.952

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.